CytomX Therapeutics Inc (CTMX) Insider Trading
- $7,816,720.00
- $51,713,192.57
- March 17, 2026
- Sean A Mccarthy
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 2, 2018 | CFO | 3,000 | $28.12 | Sell | $84,360.00 | |
| March 26, 2018 | Director | 5,000 | $31.93 | Sell | $159,650.00 | |
| March 2, 2018 | Director | 16,181 | $30.00 | Sell | $485,430.00 | |
| March 2, 2018 | CFO | 33,000 | $29.99 | Sell | $989,670.00 | |
| March 2, 2018 | Insider | 16,160 | $30.00 | Sell | $484,800.00 | |
| Feb. 28, 2018 | Insider | 23,840 | $30.00 | Sell | $715,200.00 | |
| Feb. 28, 2018 | Director | 3,819 | $30.00 | Sell | $114,570.00 | |
| Feb. 1, 2018 | CFO | 2,548 | $26.69 | Sell | $68,006.12 | |
| Jan. 5, 2018 | Director | 10,000 | $25.01 | Sell | $250,100.00 | |
| Jan. 5, 2018 | Insider | 6,526 | $25.01 | Sell | $163,215.26 | |
| Jan. 2, 2018 | Insider | 13,052 | $21.04 | Sell | $274,614.08 | |
| Jan. 2, 2018 | CFO | 2,500 | $21.11 | Sell | $52,775.00 | |
| Dec. 26, 2017 | Director | 5,000 | $22.29 | Sell | $111,450.00 | |
| Dec. 1, 2017 | CFO | 2,500 | $20.58 | Sell | $51,450.00 | |
| Dec. 1, 2017 | Insider | 14,340 | $20.60 | Sell | $295,404.00 | |
| Nov. 1, 2017 | CFO | 2,500 | $20.00 | Sell | $50,000.00 | |
| Nov. 1, 2017 | CEO | 14,342 | $19.86 | Sell | $284,832.12 | |
| Oct. 4, 2017 | Major Shareholder | 24,777 | $24.34 | Sell | $603,072.18 | |
| Oct. 4, 2017 | Insider | 48,368 | $24.34 | Sell | $1,177,277.12 | |
| Oct. 4, 2017 | Director | 10,000 | $24.27 | Sell | $242,700.00 | |
| Oct. 4, 2017 | CEO | 19,120 | $24.13 | Sell | $461,365.60 | |
| Oct. 2, 2017 | CFO | 2,500 | $18.10 | Sell | $45,250.00 | |
| Oct. 2, 2017 | Insider | 9,562 | $18.57 | Sell | $177,566.34 | |
| Sept. 26, 2017 | Director | 5,000 | $17.30 | Sell | $86,500.00 | |
| Sept. 19, 2017 | Major Shareholder | 20,000 | $18.00 | Sell | $360,000.00 | |
| Sept. 1, 2017 | Insider | 9,930 | $17.32 | Sell | $171,987.60 | |
| Sept. 1, 2017 | CFO | 2,500 | $17.17 | Sell | $42,925.00 | |
| Aug. 31, 2017 | Insider | 18,756 | $17.50 | Sell | $328,230.00 | |
| Aug. 9, 2017 | CFO | 2,500 | $15.00 | Sell | $37,500.00 | |
| Aug. 9, 2017 | Insider | 4,781 | $15.00 | Sell | $71,715.00 | |
| July 3, 2017 | CFO | 2,500 | $15.47 | Sell | $38,675.00 | |
| July 3, 2017 | Insider | 4,781 | $15.52 | Sell | $74,201.12 | |
| June 29, 2017 | Major Shareholder | 15,000 | $16.00 | Sell | $240,000.00 | |
| June 26, 2017 | Director | 5,000 | $14.61 | Sell | $73,050.00 | |
| June 26, 2017 | Insider | 4,481 | $15.00 | Sell | $67,215.00 | |
| June 5, 2017 | Insider | 300 | $15.00 | Sell | $4,500.00 | |
| May 1, 2017 | Insider | 4,781 | $15.70 | Sell | $75,061.70 | |
| April 12, 2017 | Major Shareholder | 28,357 | $16.36 | Sell | $463,920.52 | |
| April 4, 2017 | Insider | 9,562 | $17.22 | Sell | $164,657.64 | |
| March 27, 2017 | Major Shareholder | 1,650,000 | $17.39 | Sell | $28,693,500.00 | |
| March 20, 2017 | Insider | 14,343 | $19.60 | Sell | $281,122.80 | |
| March 20, 2017 | CFO | 21,517 | $19.81 | Sell | $426,251.77 | |
| March 3, 2017 | Insider | 14,343 | $15.00 | Sell | $215,145.00 | |
| Nov. 28, 2016 | Director | 38,459 | $11.56 | Sell | $444,586.04 | |
| Nov. 22, 2016 | Director | 42,550 | $11.71 | Sell | $498,260.50 | |
| Nov. 21, 2016 | Director | 45,324 | $11.61 | Sell | $526,211.64 | |
| Nov. 16, 2016 | Director | 51,581 | $11.50 | Sell | $593,181.50 | |
| Nov. 15, 2016 | Director | 33,064 | $11.48 | Sell | $379,574.72 | |
| Nov. 14, 2016 | Director | 86,270 | $11.16 | Sell | $962,773.20 | |
| Nov. 9, 2016 | Director | 13,730 | $11.03 | Sell | $151,441.90 |
Insiders are both buying and selling CytomX Therapeutics Inc stock.
The insider traders at CytomX Therapeutics Inc are: Sean A Mccarthy, Debanjan Ray, Ix L.P. Canaan, Frederick W Gluck, Lloyd A Rowland, Christopher Ogden, Marcia Belvin, Timothy M Shannon, Robert I Tepper, Jeffrey B Landau, Yu-Waye Chu, Carlos Campoy, Rachel Humphrey, Amy C Peterson, Robert C Goeltz II, James E Flynn, Rock Ventures Lp Third, Elaine V Jones, Sean A. Mccarthy, Cynthia J Ladd, Kevin P Starr, and William Michael Kavanaugh
The most active insider trader at CytomX Therapeutics Inc is Sean A Mccarthy with 32 trades.
Rock Ventures Lp Third has sold the most CytomX Therapeutics Inc stock with a total value of $57,387,000.00.
James E Flynn has bought the most CytomX Therapeutics Inc stock with a total value of $15,000,000.00.
The most recent insider trade for CytomX Therapeutics Inc was on March 17, 2026.
The single biggest insider buy for CytomX Therapeutics Inc was from James E Flynn with a total value of $7,500,000.00 on Oct. 14, 2015.
The single biggest insider sell for CytomX Therapeutics Inc was from Rock Ventures Lp Third with a total value of $28,693,500.00 on March 27, 2017.
